KRRO

Korro Bio, Inc. Common Stock
Data: 2026-08-03

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Quick Stats
Aug 03, 2026

46.0

AI Score

HOLD

0.37

Volume Ratio

Aug 11, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

KRRO Stock Summary

Last updated Aug 03, 2026

KRRO is currently trading at $10.74, positioned below its 200-day moving average of $13.83, suggesting bearish momentum. The stock has a 52-week range of $5.2044 to $55.89.

Technical Analysis: The 50-day moving average stands at $12.2, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.939, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.016, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates KRRO at 46.0/100 with a HOLD recommendation.

KRRO (Korro Bio, Inc. Common Stock) Indicators

Last updated Aug 03, 2026

Indicator Value
RSI(14) 39.939
CMF (20) 0.016
ROC (10) -6.609
ADX (14) 20.521
Indicator Value
MACD (12,26,9) -0.648
AROONOSC (14) -92.857
WILLAMS %R (14) -73.003
MFI (14) 20.997
KRRO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

KRRO Price vs Max Options Open Interest
KRRO Max Change In Options Open Interest

KRRO Options - Sort by Max open Interest (near term)

4th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KRRO Daily Out of Money Options - Sort by Max open Interest (near term)

4th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KRRO Daily In the Money Options - Sort by Max open Interest (near term)

4th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KRRO Most Active Options by Volume(near term)

4th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Korro Bio, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

KRRO Moving Averages Analysis

KRRO (Korro Bio, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 03, 2026

Days MA
10 10.87
20 12.13
30 12.56
50 12.2
100 12.24
200 13.83

KRRO Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 150.7 million
Earnings/Share ($) -12.08
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -5.1789
EPS Estimate Next Year ($) -5.0425
WallStreet Target Price ($) 20.00
Most Recent Quarter